16 employees
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
2018
$25M
from 2 investors over 2 rounds
Hopewell Therapeutics Inc. raised $25M on June 2, 2023
Investors: IMO Ventures and Morningside Venture Capital 晨兴资本